hamburger
 
Client Login Client Account Update Branch Login RM Login Add Fund SFA Login MF Login IMSS Login
 
Account Opening process for NSE/BSE Proceed to Open An Account
About us
Markets
Product & Services
Distribution
Research
Education Hub
Partner with us
Careers
Contact us
Download
NSE
Tuesday, October 22, 2024 3:59:40 PM   
Adani Enterp.  2823.80  (-113.85)  
 
Adani Ports  1362.85  (-12.65)  
 
Apollo Hospita...  6891.95  (-94.45)  
 
Asian Paints  3006.85  (-42.35)  
 
Axis Bank  1175.75  (-14.55)  
 
B P C L  322.90  (-8.75)  
 
Bajaj Auto  10368.35  (-132.15)  
 
Bajaj Finance  6677.90  (-103.00)  
 
Bajaj Finserv  1722.60  (-35.80)  
 
Bharat Electro...  271.65  (-10.65)  
 
Bharti Airtel  1692.25  (-0.30)  
 
Britannia Inds...  5727.00  (-51.30)  
 
Cipla  1510.35  (-13.40)  
 
Coal India  468.35  (-17.05)  
 
Dr Reddy's Lab...  6662.40  (-35.00)  
 
Eicher Motors  4759.05  (-51.40)  
 
Grasim Inds  2655.35  (-62.90)  
 
HCL Technologi...  1822.75  (-20.85)  
 
HDFC Bank  1714.55  (-14.15)  
 
HDFC Life Insu...  728.20  (-17.65)  
 
Hero Motocorp  5175.80  (-66.45)  
 
Hind. Unilever  2681.70  (-11.85)  
 
Hindalco Inds.  720.25  (-19.35)  
 
ICICI Bank  1267.50  (8.45)  
 
IndusInd Bank  1274.35  (-33.90)  
 
Infosys  1851.60  (-1.15)  
 
ITC  481.80  (-1.85)  
 
JSW Steel  963.65  (-17.80)  
 
Kotak Mah. Ban...  1763.15  (-26.05)  
 
Larsen & Toubr...  3511.90  (-73.70)  
 
M & M  2887.20  (-111.00)  
 
Maruti Suzuki  11923.30  (-252.60)  
 
Nestle India  2350.25  (-4.40)  
 
NTPC  415.75  (-9.25)  
 
O N G C  270.80  (-5.80)  
 
Power Grid Cor...  322.75  (-8.40)  
 
Reliance Indus...  2686.70  (-51.70)  
 
SBI Life Insur...  1698.15  (-13.70)  
 
Shriram Financ...  3254.50  (-58.80)  
 
St Bk of India  790.40  (-23.55)  
 
Sun Pharma.Ind...  1887.55  (-9.45)  
 
Tata Consumer  998.25  (-18.80)  
 
Tata Motors  879.50  (-23.80)  
 
Tata Steel  150.39  (-4.64)  
 
TCS  4015.50  (-64.35)  
 
Tech Mahindra  1696.55  (-4.65)  
 
Titan Company  3329.80  (-33.45)  
 
Trent  7497.35  (-109.20)  
 
UltraTech Cem.  10825.15  (-44.15)  
 
Wipro  545.45  (-2.65)  
 
BSE
Tuesday, October 22, 2024 4:01:00 PM   
Adani Ports  1363.30  (-11.90)  
 
Asian Paints  3010.85  (-37.90)  
 
Axis Bank  1175.80  (-14.75)  
 
Bajaj Finance  6677.40  (-107.10)  
 
Bajaj Finserv  1723.20  (-35.55)  
 
Bharti Airtel  1691.75  (-1.40)  
 
HCL Technologi...  1821.30  (-21.20)  
 
HDFC Bank  1714.10  (-14.70)  
 
Hind. Unilever  2682.05  (-11.55)  
 
ICICI Bank  1267.75  (8.40)  
 
IndusInd Bank  1277.30  (-30.70)  
 
Infosys  1850.95  (-1.55)  
 
ITC  481.70  (-1.95)  
 
JSW Steel  969.00  (-12.35)  
 
Kotak Mah. Ban...  1763.50  (-26.05)  
 
Larsen & Toubr...  3510.00  (-76.30)  
 
M & M  2883.60  (-113.45)  
 
Maruti Suzuki  11920.90  (-260.70)  
 
Nestle India  2351.05  (-3.80)  
 
NTPC  415.50  (-9.60)  
 
Power Grid Cor...  321.35  (-9.65)  
 
Reliance Indus...  2687.30  (-50.95)  
 
St Bk of India  790.45  (-23.70)  
 
Sun Pharma.Ind...  1886.65  (-9.80)  
 
Tata Motors  879.30  (-23.85)  
 
Tata Steel  150.45  (-4.55)  
 
TCS  4015.80  (-62.50)  
 
Tech Mahindra  1696.20  (-4.90)  
 
Titan Company  3331.40  (-31.40)  
 
UltraTech Cem.  10800.90  (-68.40)  
 

COMPANY NEWS


Change Company Name
Glenmark Life Sciences Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 543322 ISIN Demat INE03Q201024 Book Value 190.35 NSE Symbol GLS Div & Yield % 2.02 Market Cap (₹ Cr.) 13,617.22 P/E 30.47 EPS 36.47 Face Value 2
Glenmark Life Sciences signs Master Supply Agreement with Japanese innovator pharma company Back
(19 Jan 2024)
Glenmark Life Sciences (GLS) announced the signing of a Master Supply Agreement (MSA) with a Japanese innovator pharmaceutical company with global presence in Europe, United States and Asia.

Under the aegis of the Master Supply Agreement, Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator.

Glenmark Life Sciences will leverage its expertise in API manufacturing to support the global pharmaceutical innovator's initiative in the field of urinary anti-spasmodic therapeutics. As part of this collaboration, product portfolios of various affiliates of the global innovator may also be added in the future. The API for the finished formulation will be supplied to all major regulated markets such as United States, Europe and Japan. The estimated commercial value of this project is expected to be around $5million.